Carlyle Investment Management LLC's Net Worth
$1.12 Billion
Who is Carlyle Investment Management LLC?
Carlyle Investment Management LLC has an estimated net worth of $1.12 Billion. This is based on reported shares across multiple companies, which include NF Investment Corp., Carlyle GMS Finance, Inc., OFI Carlyle Private Credit Fund, SOLENO THERAPEUTICS INC, Vera Therapeutics, Inc., Jasper Therapeutics, Inc., eFFECTOR Therapeutics, Inc., Vertical Capital Income Fund, and MAGELLAN MIDSTREAM HOLDINGS LP.
SEC CIK
Carlyle Investment Management LLC's CIK is 0001354120
Past Insider Trading and Trends
2023 was Carlyle Investment Management LLC's most active year for acquiring shares with 5 total transactions. Carlyle Investment Management LLC's most active month to acquire stocks was the month of April. 2022 was Carlyle Investment Management LLC's most active year for disposing of shares, totalling 4 transactions. Carlyle Investment Management LLC's most active month to dispose stocks was the month of July. 2023 saw Carlyle Investment Management LLC paying a total of $7,881,097.28 for 7,095,445 shares, this is the most they've acquired in one year. In 2007 Carlyle Investment Management LLC cashed out on 31,805,358 shares for a total of $797,166,271.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
NF Investment Corp. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Carlyle GMS Finance, Inc. (CGBD) Snapshot price: $14.94
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
SOLENO THERAPEUTICS INC (SLNO) Snapshot price: $45.6
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +27.46% | 329.93K |
$1.75 | $577,377.50 | 1.53M |
Sep 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Vera Therapeutics, Inc. (VERA) Snapshot price: $37.25
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$15.63 | -$91,851.11 | 2.96M |
Aug 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Jasper Therapeutics, Inc. (JSPR) Snapshot price: $17.2
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +21.68% | 190K |
$12.95 | $2,460,500.00 | 1.07M |
Feb 8
| |||
Form 4
| +55.67% | 3.13M |
$1.50 | $4,699,999.50 | 8.76M |
Jan 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |